In addition, targeting ADAM17 by pharmacologic inhibition or gene knockout attenuates the inflammatory response in animal models of vascular damage, including hypertension, atherosclerosis, and pulmonary vascular inflammation [21, 38–40]. The gene discussed is ADAM17; the disease is Hypertension.